University of California San Francisco
Give to UCSFStudy has revealed that seniors with dementia living at home may endure more pain and have more complex or unaddressed medical needs than their counterparts in nursing homes.
UCSF scientists have for the first time decoded spoken words and phrases in real time from the brain signals that control speech.
Since 2017, UCSF researchers Winston Chiong and Eddie Chang have led a collaborative neuroethics research project funded by the NIH.
For the 21st year, UCSF Health has been listed among the top 10 hospitals nationwide in the prestigious U.S. News & World Report’s Best Hospitals survey.
Brain damage associated with MS specifically targets a common class of brain cells called projection neurons
The Susan and Bill Oberndorf Foundation has made a new commitment of $25 million to UCSF psychiatry and the neurosciences, bringing its total giving to "UCSF: The Campaign" to $50 million.
For months, the 78-year-old had been behaving strangely. Fearing the worst, his family consulted UCSF neurologist Georges Naasan, MD.
Using advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.
Today, our understanding of glioma subtypes has expanded to include the molecular and genetic variants that can influence a tumor’s development, prognosis, and response to treatment.
A new study suggests that the human brain may maintain reserves of immature neurons throughout life, using these “Peter Pan” cells in a similar manner to the neurogenesis seen in other species
Unlike other gene mutations linked to autism, which are thought to alter brain development before birth, the newly identified changes in brain signaling may occur closer to the onset of autism symptoms in the first years of life.
Excessive napping may be an early warning sign of age-related cognitive decline in older men, according to a 12-year study by UC San Francisco scientists.
UCSF Benioff Children’s Hospitals rank among the nation’s best in all 10 specialties assessed in the 2019-20 U.S. News & World Report annual survey of Best Children’s Hospitals.
Research identifies enzymes produced by two different bacterial species that work together to digest L-Dopa in the human gut. Blocking one of these bacterial enzymes could significantly boost the drug’s efficacy in these patients.